"Global Drug Delivery Device Market Overview:
Global Drug Delivery Device Market is expected to grow at a significant rate during the forecast period 2025-2032, with 2024 as the base year.
Global Drug Delivery Device Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Drug Delivery Device involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Drug Delivery Device Market:
The Drug Delivery Device Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Drug Delivery Device Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Drug Delivery Device Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Drug Delivery Device market has been segmented into:
Oral
Parenteral
Transdermal
Ocular
Pulmonary
By Application, Drug Delivery Device market has been segmented into:
Oncology
Infectious Diseases
Respiratory Diseases
Diabetes
Cardiovascular Diseases
Autoimmune Diseases
Central Nervous System Disorders
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Drug Delivery Device market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Drug Delivery Device market.
Top Key Players Covered in Drug Delivery Device market are:
Abbott Laboratories
Adherium Ltd.
Amiko Digital Health Limited
Becton
Dickinson and Company
BIOCORP
CeQur Corporation
Cognita Labs
E3D Elcam Drug Delivery Devices
H&T Presspart Manufacturing Ltd.
HCmed Innovations Co. Ltd
Medtronic plc
Novo Nordisk A/S
Phillips-Medisize
Sonceboz
Enable Injectionsinc.
NOVO Engineering
Elcam Medical
Battelle
Gerresheimer AG
Aphios
"
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Drug Delivery Device Market by Type
4.1 Drug Delivery Device Market Snapshot and Growth Engine
4.2 Drug Delivery Device Market Overview
4.3 Oral
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Oral: Geographic Segmentation Analysis
4.4 Parenteral
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Parenteral: Geographic Segmentation Analysis
4.5 Transdermal
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Transdermal: Geographic Segmentation Analysis
4.6 Ocular
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.6.3 Key Market Trends, Growth Factors and Opportunities
4.6.4 Ocular: Geographic Segmentation Analysis
4.7 Pulmonary
4.7.1 Introduction and Market Overview
4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.7.3 Key Market Trends, Growth Factors and Opportunities
4.7.4 Pulmonary: Geographic Segmentation Analysis
Chapter 5: Drug Delivery Device Market by Application
5.1 Drug Delivery Device Market Snapshot and Growth Engine
5.2 Drug Delivery Device Market Overview
5.3 Oncology
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Oncology: Geographic Segmentation Analysis
5.4 Infectious Diseases
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Infectious Diseases: Geographic Segmentation Analysis
5.5 Respiratory Diseases
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Respiratory Diseases: Geographic Segmentation Analysis
5.6 Diabetes
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Diabetes: Geographic Segmentation Analysis
5.7 Cardiovascular Diseases
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Cardiovascular Diseases: Geographic Segmentation Analysis
5.8 Autoimmune Diseases
5.8.1 Introduction and Market Overview
5.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.8.3 Key Market Trends, Growth Factors and Opportunities
5.8.4 Autoimmune Diseases: Geographic Segmentation Analysis
5.9 Central Nervous System Disorders
5.9.1 Introduction and Market Overview
5.9.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.9.3 Key Market Trends, Growth Factors and Opportunities
5.9.4 Central Nervous System Disorders: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Drug Delivery Device Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 ABBOTT LABORATORIES
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 ADHERIUM LTD.
6.4 AMIKO DIGITAL HEALTH LIMITED
6.5 BECTON
6.6 DICKINSON AND COMPANY
6.7 BIOCORP
6.8 CEQUR CORPORATION
6.9 COGNITA LABS
6.10 E3D ELCAM DRUG DELIVERY DEVICES
6.11 H&T PRESSPART MANUFACTURING LTD.
6.12 HCMED INNOVATIONS CO.
6.13 LTD.
6.14 MEDTRONIC PLC
6.15 NOVO NORDISK A/S
6.16 PHILLIPS-MEDISIZE
6.17 SONCEBOZ
6.18 ENABLE INJECTIONSINC.
6.19 NOVO ENGINEERING
6.20 ELCAM MEDICAL
6.21 BATTELLE
6.22 GERRESHEIMER AG
6.23 APHIOS
Chapter 7: Global Drug Delivery Device Market By Region
7.1 Overview
7.2. North America Drug Delivery Device Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Oral
7.2.4.2 Parenteral
7.2.4.3 Transdermal
7.2.4.4 Ocular
7.2.4.5 Pulmonary
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Oncology
7.2.5.2 Infectious Diseases
7.2.5.3 Respiratory Diseases
7.2.5.4 Diabetes
7.2.5.5 Cardiovascular Diseases
7.2.5.6 Autoimmune Diseases
7.2.5.7 Central Nervous System Disorders
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Drug Delivery Device Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Oral
7.3.4.2 Parenteral
7.3.4.3 Transdermal
7.3.4.4 Ocular
7.3.4.5 Pulmonary
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Oncology
7.3.5.2 Infectious Diseases
7.3.5.3 Respiratory Diseases
7.3.5.4 Diabetes
7.3.5.5 Cardiovascular Diseases
7.3.5.6 Autoimmune Diseases
7.3.5.7 Central Nervous System Disorders
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe Drug Delivery Device Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Oral
7.4.4.2 Parenteral
7.4.4.3 Transdermal
7.4.4.4 Ocular
7.4.4.5 Pulmonary
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Oncology
7.4.5.2 Infectious Diseases
7.4.5.3 Respiratory Diseases
7.4.5.4 Diabetes
7.4.5.5 Cardiovascular Diseases
7.4.5.6 Autoimmune Diseases
7.4.5.7 Central Nervous System Disorders
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific Drug Delivery Device Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Oral
7.5.4.2 Parenteral
7.5.4.3 Transdermal
7.5.4.4 Ocular
7.5.4.5 Pulmonary
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Oncology
7.5.5.2 Infectious Diseases
7.5.5.3 Respiratory Diseases
7.5.5.4 Diabetes
7.5.5.5 Cardiovascular Diseases
7.5.5.6 Autoimmune Diseases
7.5.5.7 Central Nervous System Disorders
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa Drug Delivery Device Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Oral
7.6.4.2 Parenteral
7.6.4.3 Transdermal
7.6.4.4 Ocular
7.6.4.5 Pulmonary
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Oncology
7.6.5.2 Infectious Diseases
7.6.5.3 Respiratory Diseases
7.6.5.4 Diabetes
7.6.5.5 Cardiovascular Diseases
7.6.5.6 Autoimmune Diseases
7.6.5.7 Central Nervous System Disorders
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Drug Delivery Device Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Oral
7.7.4.2 Parenteral
7.7.4.3 Transdermal
7.7.4.4 Ocular
7.7.4.5 Pulmonary
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Oncology
7.7.5.2 Infectious Diseases
7.7.5.3 Respiratory Diseases
7.7.5.4 Diabetes
7.7.5.5 Cardiovascular Diseases
7.7.5.6 Autoimmune Diseases
7.7.5.7 Central Nervous System Disorders
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Drug Delivery Device Scope:
|
Report Data
|
Drug Delivery Device Market
|
|
Drug Delivery Device Market Size in 2025
|
USD XX million
|
|
Drug Delivery Device CAGR 2025 - 2032
|
XX%
|
|
Drug Delivery Device Base Year
|
2024
|
|
Drug Delivery Device Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Abbott Laboratories, Adherium Ltd., Amiko Digital Health Limited, Becton, Dickinson and Company, BIOCORP, CeQur Corporation, Cognita Labs, E3D Elcam Drug Delivery Devices, H&T Presspart Manufacturing Ltd., HCmed Innovations Co., Ltd., Medtronic plc, Novo Nordisk A/S, Phillips-Medisize, Sonceboz, Enable Injectionsinc., NOVO Engineering, Elcam Medical, Battelle, Gerresheimer AG, Aphios.
|
|
Key Segments
|
By Type
Oral
Parenteral
Transdermal
Ocular
Pulmonary
By Applications
Oncology
Infectious Diseases
Respiratory Diseases
Diabetes
Cardiovascular Diseases
Autoimmune Diseases
Central Nervous System Disorders
|
